Wockhardt Limited
WOCKPHARMA
株式のランク
#4533
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
株価
$20.65
時価総額
$3.36B
変化（1日）
-1.84%
変化（1年）
32.42%
国
IN
取引 Wockhardt Limited (WOCKPHARMA)
カテゴリー
Healthcare
Wockhardt Limited（WOCKPHARMA）の株式分割履歴
Wockhardt Limited株（シンボル：WOCKPHARMA）は合計で2回の株式分割を実施しました。
最新の株式分割はMar 08, 2022に行われました。
Apr 28, 2004より前に購入されたWOCKPHARMA株は、現在3.255WOCKPHARMA株に相当します。
最新の株式分割はMar 08, 2022に行われました。
Apr 28, 2004より前に購入されたWOCKPHARMA株は、現在3.255WOCKPHARMA株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 2022-03-08 | 217:200 | x1.085 | x3.255 |
| 2004-04-28 | 3:1 | x3 | x3 |
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 0 | - |
US
|
|
| 0 | - |
SE
|
|
| 0 | - |
FR
|
|
| 0 | - |
IT
|
|
| 0 | - |
US
|
